The 10th International Congress on Drug Therapy in HIV Infection, Glasgow, November 2010

Oral

1 Fatal and non-fatal AIDS and non-AIDS events in HIV-1 infected patients with high CD4 counts. J Reekie, J Gatell, I Yust, E Bakowska, A Rachmanova, M Losso, M Krasnov, P Francioli, J Kowalska, A Mocroft for the EuroSIDA study group.
Presentation

2 Vitamin D and clinical disease progression n HIV infection: results from the EuroSIDA study. JP Viard, JC Souberbielle, O Kirk, B Knysz, M Losso, J Gatell, C Pedersen, JR Bogner, A Mocroft, JD Lundgren
Presentation

Posters

1 Changing Antiretrovirals whilst Viral Load <50 copies/ml and Relationship with CD4 Count Changes. A Mocroft, J Reekie, C Katlama, A Lazzarin, M Ristola, H Sambatakou, J Gasiorowski, D Jevtovic, O Kirk and JD Lundgren for the EuroSIDA study group. Poster (80 KB)

2 Fatal and Non-fatal AIDS and Non-AIDS Events in HIV-1 Infected Patients with High CD4 Counts According to Viral Load Strata. J Reekie, J Gatell, I Yust, E Bakowska, A Rachmanova, M Losso, M Krasnov, P Francioli, J Kowalska, A Mocroft for the EuroSIDA study group. Poster (99KB)

3 Chronic Kidney Disease in Patients with Normal eGFR at Baseline - Results from EuroSIDA. L Ryom, A Mocroft, P Reiss, B Ledergerber, S De Wit, D Duiculescu, AD Monforte, M Murphy, JD Lundgren, O Kirk for the EuroSIDA study group. Poster (99 KB)

4 Relating Protease Inhibitor Resistance at Time of Virological Failure with Drug Exposure. M Van Luin, WP Bannister, R Paredes, AN Phillip, J Bruun, J Van Lunzen, O Kirk, A d'Arminio Monforte, A Cozzi-Lepri, DM Burger, and the EuroSIDA group. Poster (80 KB)

5 Vitamin D and Clinical Disease Progression in HIV Infection: Results from the EuroSIDA Study. JP Viard, JC Souberbielle, O Kirk, B Knysz, M Losso, J Gatell, C Pedersen, JR Bogner, A Mocroft, JD Lundgren for the EuroSIDA study group. Poster (98 KB)

17th Conference on Retroviruses and Opportunistic Infections, San Francisco, February 2010

Oral Presentations

Chronic kidney disease (CKD) and exposure to antiretroviral drugs (ARVs) in a large cohort with long-term follow-up: the EuroSIDA Study. O Kirk, A Mocroft, P Reiss, S De Wit, D Sedlacek, M Beniowski, J Gatell, A Phillips, B Ledergerber, J Lundgren, for the EuroSIDA study group.